Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal Subjects

New England Journal of Medicine

Volumn 320, Issue 18, 1989, Pages 1165-1172

  Suffredini, Anthony F ^a   Harpel, Peter C ^a   Parrillo, Joseph E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; PLASMINOGEN ACTIVATOR;

ADULT; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0024562002     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198905043201802     Document Type: Article

References (46)

1. Parrillo JE. Shock and hypotension. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison's principles of internal medicine. 12th ed. New York: McGraw-Hill (in press).
2. Coalson JJ. Pathology of sepsis, septic shock, and multiple organ failure. In: Sibbald WJ, Sprung CL, eds. Perspectives on sepsis and septic shock. Fullerton, Calif.: Society of Critical Care Medicine, 1986:27–59.
3. McGovern VJ. Shock revisited. Pathol Annu 1984; 19: 15–36.
4. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417–32.
5. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379–85.
6. van Deventer SJH, Buller HR, ten Cate JW, Sturk A, Pauw W. Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet 1988; 1: 605–9.
7. Danner RL, Elin RJ, Hosseini JM, Schlesinger T, Reilly JM, Parrillo JE. Endotoxemia in critically ill patients. Clin Res 1988; 36: 370A. abstract.
8. Hekman CM, Loskutoff DL. Fibrinolytic pathways and the endothelium. Semin Thromb Hemost 1987; 13: 514–27.
9. Colucci M, Balconi G, Lorenzet R, et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893–6.
10. Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818–24.
11. Stern DM, Bank I, Nawroth PP, et al. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med 1985; 162: 1223–35.
12. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985; 76: 2003–11.
13. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381–7.
14. Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260–6.
15. Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986; 78: 587–91.
16. Krishnamurti C, Barr CF, Hassett MA, Young GD, Alving BM. Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbits. Blood 1987; 69: 798–803.
17. Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. J Lab Clin Med 1987; 109: 97–104.
18. Crutchley DJ, Conanan LB. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. J Biol Chem 1986; 261: 154–9.
19. Gralnick HR, Elin RJ, Abrams E, Givelber H, Wolff SM. Effects of endotoxin (LPS) on blood coagulation in humans. Clin Res 1976; 24: 344A. abstract.
20. Stern D, Nawroth P, Handley D, Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci USA 1985; 82: 2523–7.
21. Schorer AE, Moldow CF, Rick ME. Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells. Br J Haematol 1987; 67: 193–7.
22. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124–30.
23. Suffredini AF, Parker MM, Brenner M, Schlesinger T, Parrillo JE. Endotoxin (E) administration produces abnormal cardiovascular (CV) responses in normal humans. Clin Res 1987; 35: 386A. abstract.
24. Suffredini AF, Shelhamer JH, Neumann RD, Brenner M, Parrillo JE. Intravenous endotoxin (E) to normal humans causes gas exchange abnormalities and increased alveolar epithelial permeability. Clin Res 1988; 36: 511A. abstract.
25. Hochstein HD, Mills DF, Outschoorn AS, Rastogi SC. The processing and collaborative assay of a reference endotoxin. J Biol Stand 1983; 11: 251–60.
26. Elin RJ, Wolff SM, McAdam KP, et al. Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J Infect Dis 1981; 144: 329–36.
27. Harpel PC. α2-Plasmin inhibitor and α2-macroglobulin-plasmin complexes in plasma: quantification by an enzyme-linked differential antibody immunosorbent assay. J Clin Invest 1981; 68: 46–55.
28. Eriksson E, Rånby M, Gyzander E, Risberg B. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. Thromb Res 1988; 50: 91–101.
29. Levin RI, Harpel PC, Weil D, Chang T-S, Rifkin DB. Aspirin inhibits vascular plasminogen activator activity in vivo: studies utilizing a new assay to quantify plasminogen activator activity. J Clin Invest 1984; 74: 571–80.
30. Brower MS, Harpel PC. Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes. Blood 1983; 61: 842–9.
31. Zimmerman TS, Hoyer LW, Dickson L, Edgington TS. Determination of the von Willebrand's disease antigen (factor VIII–related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med 1975; 86: 152–9.
32. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J Biol Chem 1982; 257: 2912–9.
33. Hajjar KA, Hamel NM, Harpel PC, Nachman RL. Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin invest 1987; 80: 1712–9.
34. Engebretsen LF, Kierulf P, Brandtzaeg P. Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease. Thromb Res 1986; 42: 713–6.
35. Kruithof EK, Gudinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost 1988; 59: 7–12.
36. Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med 1986; 163: 1595–600.
37. Hesse DG, Tracey KJ, Fong Y, et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166: 147–53.
38. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481–6.
39. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 4533–7.
40. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DL. Cytokine activation of vascular endothelium: effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988; 263: 5797–803.
41. Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988; 72: 1467–73.
42. Smedley LA, Tonnesen MG, Sandhaus RA, et al. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986; 77: 1233–43.
43. Duswald KH, Jochum M, Schramm W, Fritz H. Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery 1985; 98: 892–9.
44. Holmberg L, Nilsson IM. AHF related protein in clinical praxis. Scand J Haematol 1974; 12: 221–31.
45. Carvalho ACA, Bellman SM, Saullo VJ, Quinn D, Zapol WM. Altered factor VIII in acute respiratory failure. N Engl J Med 1982; 307: 1113–9.
46. Ribes JA, Francis CW, Wagner DD. Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest 1987; 79: 117–23.